ETS1 and RBPJ Transcriptionally Regulate METTL14 to Suppress TGF-(31-induced Epithelial-Mesenchymal Transition in Human Bronchial Epithelial Cells
Jia-he Chen,Jiao-jiao Li,Qiang Tian,Dan-dan Feng,Li-li Zhuang,Qian Cao,Guo-ping Zhou,Rui Jin
DOI: https://doi.org/10.1016/j.bbadis.2024.167349
2024-01-01
Biochimica et Biophysica Acta - Molecular Basis of Disease
Abstract:Asthma is a chronic respiratory disease characterized by airway inflammation and remodeling. Epithelialmesenchymal transition (EMT) of bronchial epithelial cells is considered to be a crucial player in asthma. Methyltransferase-like 14 (METTL14), an RNA methyltransferase, is implicated in multiple pathological processes, including EMT, cell proliferation and migration. However, the role of METTL14 in asthma remains uncertain. This research aimed to explore the biological functions of METTL14 in asthma and its underlying upstream mechanisms. METTL14 expression was down-regulated in asthmatic from three GEO datasets (GSE104468, GSE165934, and GSE74986). Consistent with this trend, METTL14 was decreased in the lung tissues of OVA-induced asthmatic mice and transforming growth factor-(31 (TGF-(31)-stimulated human bronchial epithelial cells (Beas-2B) in this study. Overexpression of METTL14 caused reduction in mesenchymal markers (FN1, N-cad, Col-1 and alpha-SMA) in TGF-(31-treated cells, but caused increase in epithelial markers (E-cad), thus inhibiting EMT. Also, METTL14 suppressed the proliferation and migration ability of TGF-(31-treated Beas-2B cells. Two transcription factors, ETS1 and RBPJ, could both bind to the promoter region of METTL14 and drive its expression. Elevating METTL14 expression could reversed EMT, cell proliferation and migration promoted by ETS1 or RBPJ deficiency. These results indicate that the ETS1/METTL14 and RBPJ/METTL14 transcription axes exhibit anti-EMT, anti-proliferation and anti-migration functions in TGF-(31-induced bronchial epithelial cells, implying that METTL14 may be considered an alternative candidate target for the treatment of asthma.